Patient Characteristics (N = 37)
| . | No. . | % or Range . |
|---|---|---|
| Age | 58 | 29-81 |
| Sex | ||
| Female | 16 | 43 |
| Male | 21 | 57 |
| Histologic grade* | ||
| Low | 34 | 92 |
| A | 4 | 11 |
| B | 21 | 57 |
| C | 9 | 24 |
| Intermediate | 3 | 8 |
| D | 2 | 5 |
| G | 1 | 3 |
| Stage at diagnosis | ||
| I | 5 | 14 |
| II | 2 | 5 |
| III | 10 | 27 |
| IV | 18 | 49 |
| Unknown | 2 | 5 |
| Prior Therapy | ||
| Chemotherapy | 37 | 100 |
| Median no. of regimens | 2 | 1-5 |
| Time from last Rx median (mo) | 10.2 | 0.9-70.4 |
| Radiotherapy | 13 | 35 |
| ABMT | 3 | 8 |
| All therapy | 37 | 100 |
| Median no. | 2 | 1-8 |
| Time from last Rx, median (mo) | 7.2 | 0.9-67.9 |
| First chemotherapy | ||
| Single agent | 9 | 25 |
| COP or CP | 11 | 31 |
| Aggressive combination | 17 | 44 |
| Response to first chemotherapy | ||
| CR or PR | 29 | 81 |
| Duration, median (mo) | 12 | |
| No response | 5 | 14 |
| Unknown | 2 | 5 |
| Response to last therapy | ||
| CP or PR | 25 | 86 |
| Duration, median (mo) | 12 | |
| Unknown | 2 | 5 |
| . | No. . | % or Range . |
|---|---|---|
| Age | 58 | 29-81 |
| Sex | ||
| Female | 16 | 43 |
| Male | 21 | 57 |
| Histologic grade* | ||
| Low | 34 | 92 |
| A | 4 | 11 |
| B | 21 | 57 |
| C | 9 | 24 |
| Intermediate | 3 | 8 |
| D | 2 | 5 |
| G | 1 | 3 |
| Stage at diagnosis | ||
| I | 5 | 14 |
| II | 2 | 5 |
| III | 10 | 27 |
| IV | 18 | 49 |
| Unknown | 2 | 5 |
| Prior Therapy | ||
| Chemotherapy | 37 | 100 |
| Median no. of regimens | 2 | 1-5 |
| Time from last Rx median (mo) | 10.2 | 0.9-70.4 |
| Radiotherapy | 13 | 35 |
| ABMT | 3 | 8 |
| All therapy | 37 | 100 |
| Median no. | 2 | 1-8 |
| Time from last Rx, median (mo) | 7.2 | 0.9-67.9 |
| First chemotherapy | ||
| Single agent | 9 | 25 |
| COP or CP | 11 | 31 |
| Aggressive combination | 17 | 44 |
| Response to first chemotherapy | ||
| CR or PR | 29 | 81 |
| Duration, median (mo) | 12 | |
| No response | 5 | 14 |
| Unknown | 2 | 5 |
| Response to last therapy | ||
| CP or PR | 25 | 86 |
| Duration, median (mo) | 12 | |
| Unknown | 2 | 5 |
Histologic group based on Working Formulation.